Medical Care
Global Generic Injectable Drugs Market Research Report 2025
- Apr 16, 25
- ID: 187715
- Pages: 89
- Figures: 89
- Views: 31
The global market for Generic Injectable Drugs was valued at US$ 32770 million in the year 2024 and is projected to reach a revised size of US$ 41560 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
In the segment of generic sterile injectable drugs, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
This report aims to provide a comprehensive presentation of the global market for Generic Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injectable Drugs.
The Generic Injectable Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Generic Injectable Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Injectable Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Segment by Type
Small Molecule
Large Molecule
Segment by Application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Injectable Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
In the segment of generic sterile injectable drugs, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
This report aims to provide a comprehensive presentation of the global market for Generic Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injectable Drugs.
The Generic Injectable Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Generic Injectable Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Injectable Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Segment by Type
Small Molecule
Large Molecule
Segment by Application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Injectable Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Injectable Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule
1.2.3 Large Molecule
1.3 Market by Application
1.3.1 Global Generic Injectable Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Injectable Drugs Market Perspective (2020-2031)
2.2 Global Generic Injectable Drugs Growth Trends by Region
2.2.1 Global Generic Injectable Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Generic Injectable Drugs Historic Market Size by Region (2020-2025)
2.2.3 Generic Injectable Drugs Forecasted Market Size by Region (2026-2031)
2.3 Generic Injectable Drugs Market Dynamics
2.3.1 Generic Injectable Drugs Industry Trends
2.3.2 Generic Injectable Drugs Market Drivers
2.3.3 Generic Injectable Drugs Market Challenges
2.3.4 Generic Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Injectable Drugs Players by Revenue
3.1.1 Global Top Generic Injectable Drugs Players by Revenue (2020-2025)
3.1.2 Global Generic Injectable Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Generic Injectable Drugs Revenue
3.4 Global Generic Injectable Drugs Market Concentration Ratio
3.4.1 Global Generic Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Injectable Drugs Revenue in 2024
3.5 Global Key Players of Generic Injectable Drugs Head office and Area Served
3.6 Global Key Players of Generic Injectable Drugs, Product and Application
3.7 Global Key Players of Generic Injectable Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Injectable Drugs Breakdown Data by Type
4.1 Global Generic Injectable Drugs Historic Market Size by Type (2020-2025)
4.2 Global Generic Injectable Drugs Forecasted Market Size by Type (2026-2031)
5 Generic Injectable Drugs Breakdown Data by Application
5.1 Global Generic Injectable Drugs Historic Market Size by Application (2020-2025)
5.2 Global Generic Injectable Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Generic Injectable Drugs Market Size (2020-2031)
6.2 North America Generic Injectable Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Generic Injectable Drugs Market Size by Country (2020-2025)
6.4 North America Generic Injectable Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Injectable Drugs Market Size (2020-2031)
7.2 Europe Generic Injectable Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Generic Injectable Drugs Market Size by Country (2020-2025)
7.4 Europe Generic Injectable Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Injectable Drugs Market Size (2020-2031)
8.2 Asia-Pacific Generic Injectable Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Generic Injectable Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Generic Injectable Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Injectable Drugs Market Size (2020-2031)
9.2 Latin America Generic Injectable Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Generic Injectable Drugs Market Size by Country (2020-2025)
9.4 Latin America Generic Injectable Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Injectable Drugs Market Size (2020-2031)
10.2 Middle East & Africa Generic Injectable Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Generic Injectable Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Generic Injectable Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Details
11.1.2 Hospira (Pfizer Inc.) Business Overview
11.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Introduction
11.1.4 Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2020-2025)
11.1.5 Hospira (Pfizer Inc.) Recent Development
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Details
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Generic Injectable Drugs Introduction
11.2.4 Fresenius Kabi Revenue in Generic Injectable Drugs Business (2020-2025)
11.2.5 Fresenius Kabi Recent Development
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Details
11.3.2 Sandoz (Novartis) Business Overview
11.3.3 Sandoz (Novartis) Generic Injectable Drugs Introduction
11.3.4 Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2020-2025)
11.3.5 Sandoz (Novartis) Recent Development
11.4 Hikma Pharmaceuticals PLC
11.4.1 Hikma Pharmaceuticals PLC Company Details
11.4.2 Hikma Pharmaceuticals PLC Business Overview
11.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Introduction
11.4.4 Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2020-2025)
11.4.5 Hikma Pharmaceuticals PLC Recent Development
11.5 Dr. Reddy’s Laboratories Ltd
11.5.1 Dr. Reddy’s Laboratories Ltd Company Details
11.5.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Introduction
11.5.4 Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2020-2025)
11.5.5 Dr. Reddy’s Laboratories Ltd Recent Development
11.6 Grifols
11.6.1 Grifols Company Details
11.6.2 Grifols Business Overview
11.6.3 Grifols Generic Injectable Drugs Introduction
11.6.4 Grifols Revenue in Generic Injectable Drugs Business (2020-2025)
11.6.5 Grifols Recent Development
11.7 Nichi-Iko Group (Sagent)
11.7.1 Nichi-Iko Group (Sagent) Company Details
11.7.2 Nichi-Iko Group (Sagent) Business Overview
11.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Introduction
11.7.4 Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2020-2025)
11.7.5 Nichi-Iko Group (Sagent) Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Generic Injectable Drugs Introduction
11.8.4 Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2020-2025)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Auromedics
11.9.1 Auromedics Company Details
11.9.2 Auromedics Business Overview
11.9.3 Auromedics Generic Injectable Drugs Introduction
11.9.4 Auromedics Revenue in Generic Injectable Drugs Business (2020-2025)
11.9.5 Auromedics Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Generic Injectable Drugs Introduction
11.10.4 Sanofi Revenue in Generic Injectable Drugs Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Gland Pharma
11.11.1 Gland Pharma Company Details
11.11.2 Gland Pharma Business Overview
11.11.3 Gland Pharma Generic Injectable Drugs Introduction
11.11.4 Gland Pharma Revenue in Generic Injectable Drugs Business (2020-2025)
11.11.5 Gland Pharma Recent Development
11.12 Endo International PLC
11.12.1 Endo International PLC Company Details
11.12.2 Endo International PLC Business Overview
11.12.3 Endo International PLC Generic Injectable Drugs Introduction
11.12.4 Endo International PLC Revenue in Generic Injectable Drugs Business (2020-2025)
11.12.5 Endo International PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Injectable Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule
1.2.3 Large Molecule
1.3 Market by Application
1.3.1 Global Generic Injectable Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Injectable Drugs Market Perspective (2020-2031)
2.2 Global Generic Injectable Drugs Growth Trends by Region
2.2.1 Global Generic Injectable Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Generic Injectable Drugs Historic Market Size by Region (2020-2025)
2.2.3 Generic Injectable Drugs Forecasted Market Size by Region (2026-2031)
2.3 Generic Injectable Drugs Market Dynamics
2.3.1 Generic Injectable Drugs Industry Trends
2.3.2 Generic Injectable Drugs Market Drivers
2.3.3 Generic Injectable Drugs Market Challenges
2.3.4 Generic Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Injectable Drugs Players by Revenue
3.1.1 Global Top Generic Injectable Drugs Players by Revenue (2020-2025)
3.1.2 Global Generic Injectable Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Generic Injectable Drugs Revenue
3.4 Global Generic Injectable Drugs Market Concentration Ratio
3.4.1 Global Generic Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Injectable Drugs Revenue in 2024
3.5 Global Key Players of Generic Injectable Drugs Head office and Area Served
3.6 Global Key Players of Generic Injectable Drugs, Product and Application
3.7 Global Key Players of Generic Injectable Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Injectable Drugs Breakdown Data by Type
4.1 Global Generic Injectable Drugs Historic Market Size by Type (2020-2025)
4.2 Global Generic Injectable Drugs Forecasted Market Size by Type (2026-2031)
5 Generic Injectable Drugs Breakdown Data by Application
5.1 Global Generic Injectable Drugs Historic Market Size by Application (2020-2025)
5.2 Global Generic Injectable Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Generic Injectable Drugs Market Size (2020-2031)
6.2 North America Generic Injectable Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Generic Injectable Drugs Market Size by Country (2020-2025)
6.4 North America Generic Injectable Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Injectable Drugs Market Size (2020-2031)
7.2 Europe Generic Injectable Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Generic Injectable Drugs Market Size by Country (2020-2025)
7.4 Europe Generic Injectable Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Injectable Drugs Market Size (2020-2031)
8.2 Asia-Pacific Generic Injectable Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Generic Injectable Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Generic Injectable Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Injectable Drugs Market Size (2020-2031)
9.2 Latin America Generic Injectable Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Generic Injectable Drugs Market Size by Country (2020-2025)
9.4 Latin America Generic Injectable Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Injectable Drugs Market Size (2020-2031)
10.2 Middle East & Africa Generic Injectable Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Generic Injectable Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Generic Injectable Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Details
11.1.2 Hospira (Pfizer Inc.) Business Overview
11.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Introduction
11.1.4 Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2020-2025)
11.1.5 Hospira (Pfizer Inc.) Recent Development
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Details
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Generic Injectable Drugs Introduction
11.2.4 Fresenius Kabi Revenue in Generic Injectable Drugs Business (2020-2025)
11.2.5 Fresenius Kabi Recent Development
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Details
11.3.2 Sandoz (Novartis) Business Overview
11.3.3 Sandoz (Novartis) Generic Injectable Drugs Introduction
11.3.4 Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2020-2025)
11.3.5 Sandoz (Novartis) Recent Development
11.4 Hikma Pharmaceuticals PLC
11.4.1 Hikma Pharmaceuticals PLC Company Details
11.4.2 Hikma Pharmaceuticals PLC Business Overview
11.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Introduction
11.4.4 Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2020-2025)
11.4.5 Hikma Pharmaceuticals PLC Recent Development
11.5 Dr. Reddy’s Laboratories Ltd
11.5.1 Dr. Reddy’s Laboratories Ltd Company Details
11.5.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Introduction
11.5.4 Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2020-2025)
11.5.5 Dr. Reddy’s Laboratories Ltd Recent Development
11.6 Grifols
11.6.1 Grifols Company Details
11.6.2 Grifols Business Overview
11.6.3 Grifols Generic Injectable Drugs Introduction
11.6.4 Grifols Revenue in Generic Injectable Drugs Business (2020-2025)
11.6.5 Grifols Recent Development
11.7 Nichi-Iko Group (Sagent)
11.7.1 Nichi-Iko Group (Sagent) Company Details
11.7.2 Nichi-Iko Group (Sagent) Business Overview
11.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Introduction
11.7.4 Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2020-2025)
11.7.5 Nichi-Iko Group (Sagent) Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Generic Injectable Drugs Introduction
11.8.4 Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2020-2025)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Auromedics
11.9.1 Auromedics Company Details
11.9.2 Auromedics Business Overview
11.9.3 Auromedics Generic Injectable Drugs Introduction
11.9.4 Auromedics Revenue in Generic Injectable Drugs Business (2020-2025)
11.9.5 Auromedics Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Generic Injectable Drugs Introduction
11.10.4 Sanofi Revenue in Generic Injectable Drugs Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Gland Pharma
11.11.1 Gland Pharma Company Details
11.11.2 Gland Pharma Business Overview
11.11.3 Gland Pharma Generic Injectable Drugs Introduction
11.11.4 Gland Pharma Revenue in Generic Injectable Drugs Business (2020-2025)
11.11.5 Gland Pharma Recent Development
11.12 Endo International PLC
11.12.1 Endo International PLC Company Details
11.12.2 Endo International PLC Business Overview
11.12.3 Endo International PLC Generic Injectable Drugs Introduction
11.12.4 Endo International PLC Revenue in Generic Injectable Drugs Business (2020-2025)
11.12.5 Endo International PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Generic Injectable Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule
Table 3. Key Players of Large Molecule
Table 4. Global Generic Injectable Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Generic Injectable Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Generic Injectable Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Generic Injectable Drugs Market Share by Region (2020-2025)
Table 8. Global Generic Injectable Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Generic Injectable Drugs Market Share by Region (2026-2031)
Table 10. Generic Injectable Drugs Market Trends
Table 11. Generic Injectable Drugs Market Drivers
Table 12. Generic Injectable Drugs Market Challenges
Table 13. Generic Injectable Drugs Market Restraints
Table 14. Global Generic Injectable Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Generic Injectable Drugs Market Share by Players (2020-2025)
Table 16. Global Top Generic Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectable Drugs as of 2024)
Table 17. Ranking of Global Top Generic Injectable Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Generic Injectable Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Generic Injectable Drugs, Headquarters and Area Served
Table 20. Global Key Players of Generic Injectable Drugs, Product and Application
Table 21. Global Key Players of Generic Injectable Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Injectable Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Generic Injectable Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Generic Injectable Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Generic Injectable Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Generic Injectable Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Generic Injectable Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global Generic Injectable Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Generic Injectable Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America Generic Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Generic Injectable Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Generic Injectable Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Generic Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Generic Injectable Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Generic Injectable Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Generic Injectable Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Generic Injectable Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Generic Injectable Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Generic Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Generic Injectable Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Generic Injectable Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Generic Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Generic Injectable Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Generic Injectable Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Hospira (Pfizer Inc.) Company Details
Table 47. Hospira (Pfizer Inc.) Business Overview
Table 48. Hospira (Pfizer Inc.) Generic Injectable Drugs Product
Table 49. Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 50. Hospira (Pfizer Inc.) Recent Development
Table 51. Fresenius Kabi Company Details
Table 52. Fresenius Kabi Business Overview
Table 53. Fresenius Kabi Generic Injectable Drugs Product
Table 54. Fresenius Kabi Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 55. Fresenius Kabi Recent Development
Table 56. Sandoz (Novartis) Company Details
Table 57. Sandoz (Novartis) Business Overview
Table 58. Sandoz (Novartis) Generic Injectable Drugs Product
Table 59. Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 60. Sandoz (Novartis) Recent Development
Table 61. Hikma Pharmaceuticals PLC Company Details
Table 62. Hikma Pharmaceuticals PLC Business Overview
Table 63. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product
Table 64. Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 65. Hikma Pharmaceuticals PLC Recent Development
Table 66. Dr. Reddy’s Laboratories Ltd Company Details
Table 67. Dr. Reddy’s Laboratories Ltd Business Overview
Table 68. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product
Table 69. Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 70. Dr. Reddy’s Laboratories Ltd Recent Development
Table 71. Grifols Company Details
Table 72. Grifols Business Overview
Table 73. Grifols Generic Injectable Drugs Product
Table 74. Grifols Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 75. Grifols Recent Development
Table 76. Nichi-Iko Group (Sagent) Company Details
Table 77. Nichi-Iko Group (Sagent) Business Overview
Table 78. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product
Table 79. Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 80. Nichi-Iko Group (Sagent) Recent Development
Table 81. Teva Pharmaceutical Company Details
Table 82. Teva Pharmaceutical Business Overview
Table 83. Teva Pharmaceutical Generic Injectable Drugs Product
Table 84. Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 85. Teva Pharmaceutical Recent Development
Table 86. Auromedics Company Details
Table 87. Auromedics Business Overview
Table 88. Auromedics Generic Injectable Drugs Product
Table 89. Auromedics Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 90. Auromedics Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Generic Injectable Drugs Product
Table 94. Sanofi Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Gland Pharma Company Details
Table 97. Gland Pharma Business Overview
Table 98. Gland Pharma Generic Injectable Drugs Product
Table 99. Gland Pharma Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 100. Gland Pharma Recent Development
Table 101. Endo International PLC Company Details
Table 102. Endo International PLC Business Overview
Table 103. Endo International PLC Generic Injectable Drugs Product
Table 104. Endo International PLC Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 105. Endo International PLC Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Generic Injectable Drugs Picture
Figure 2. Global Generic Injectable Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Generic Injectable Drugs Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule Features
Figure 5. Large Molecule Features
Figure 6. Global Generic Injectable Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Generic Injectable Drugs Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Anesthesia Case Studies
Figure 10. Anti-Infectives Case Studies
Figure 11. Parenteral Nutrition Case Studies
Figure 12. Cardiovascular Diseases Case Studies
Figure 13. Generic Injectable Drugs Report Years Considered
Figure 14. Global Generic Injectable Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Generic Injectable Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Generic Injectable Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Generic Injectable Drugs Market Share by Players in 2024
Figure 18. Global Top Generic Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectable Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Generic Injectable Drugs Revenue in 2024
Figure 20. North America Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Generic Injectable Drugs Market Share by Country (2020-2031)
Figure 22. United States Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Generic Injectable Drugs Market Share by Country (2020-2031)
Figure 26. Germany Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Generic Injectable Drugs Market Share by Region (2020-2031)
Figure 34. China Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Generic Injectable Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Generic Injectable Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Hospira (Pfizer Inc.) Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 50. Fresenius Kabi Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 51. Sandoz (Novartis) Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 52. Hikma Pharmaceuticals PLC Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 53. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 54. Grifols Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 55. Nichi-Iko Group (Sagent) Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 56. Teva Pharmaceutical Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 57. Auromedics Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 58. Sanofi Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 59. Gland Pharma Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 60. Endo International PLC Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Generic Injectable Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule
Table 3. Key Players of Large Molecule
Table 4. Global Generic Injectable Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Generic Injectable Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Generic Injectable Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Generic Injectable Drugs Market Share by Region (2020-2025)
Table 8. Global Generic Injectable Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Generic Injectable Drugs Market Share by Region (2026-2031)
Table 10. Generic Injectable Drugs Market Trends
Table 11. Generic Injectable Drugs Market Drivers
Table 12. Generic Injectable Drugs Market Challenges
Table 13. Generic Injectable Drugs Market Restraints
Table 14. Global Generic Injectable Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Generic Injectable Drugs Market Share by Players (2020-2025)
Table 16. Global Top Generic Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectable Drugs as of 2024)
Table 17. Ranking of Global Top Generic Injectable Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Generic Injectable Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Generic Injectable Drugs, Headquarters and Area Served
Table 20. Global Key Players of Generic Injectable Drugs, Product and Application
Table 21. Global Key Players of Generic Injectable Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Injectable Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Generic Injectable Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Generic Injectable Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Generic Injectable Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Generic Injectable Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Generic Injectable Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global Generic Injectable Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Generic Injectable Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America Generic Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Generic Injectable Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Generic Injectable Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Generic Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Generic Injectable Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Generic Injectable Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Generic Injectable Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Generic Injectable Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Generic Injectable Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Generic Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Generic Injectable Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Generic Injectable Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Generic Injectable Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Generic Injectable Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Generic Injectable Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Hospira (Pfizer Inc.) Company Details
Table 47. Hospira (Pfizer Inc.) Business Overview
Table 48. Hospira (Pfizer Inc.) Generic Injectable Drugs Product
Table 49. Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 50. Hospira (Pfizer Inc.) Recent Development
Table 51. Fresenius Kabi Company Details
Table 52. Fresenius Kabi Business Overview
Table 53. Fresenius Kabi Generic Injectable Drugs Product
Table 54. Fresenius Kabi Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 55. Fresenius Kabi Recent Development
Table 56. Sandoz (Novartis) Company Details
Table 57. Sandoz (Novartis) Business Overview
Table 58. Sandoz (Novartis) Generic Injectable Drugs Product
Table 59. Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 60. Sandoz (Novartis) Recent Development
Table 61. Hikma Pharmaceuticals PLC Company Details
Table 62. Hikma Pharmaceuticals PLC Business Overview
Table 63. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product
Table 64. Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 65. Hikma Pharmaceuticals PLC Recent Development
Table 66. Dr. Reddy’s Laboratories Ltd Company Details
Table 67. Dr. Reddy’s Laboratories Ltd Business Overview
Table 68. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product
Table 69. Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 70. Dr. Reddy’s Laboratories Ltd Recent Development
Table 71. Grifols Company Details
Table 72. Grifols Business Overview
Table 73. Grifols Generic Injectable Drugs Product
Table 74. Grifols Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 75. Grifols Recent Development
Table 76. Nichi-Iko Group (Sagent) Company Details
Table 77. Nichi-Iko Group (Sagent) Business Overview
Table 78. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product
Table 79. Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 80. Nichi-Iko Group (Sagent) Recent Development
Table 81. Teva Pharmaceutical Company Details
Table 82. Teva Pharmaceutical Business Overview
Table 83. Teva Pharmaceutical Generic Injectable Drugs Product
Table 84. Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 85. Teva Pharmaceutical Recent Development
Table 86. Auromedics Company Details
Table 87. Auromedics Business Overview
Table 88. Auromedics Generic Injectable Drugs Product
Table 89. Auromedics Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 90. Auromedics Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Generic Injectable Drugs Product
Table 94. Sanofi Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Gland Pharma Company Details
Table 97. Gland Pharma Business Overview
Table 98. Gland Pharma Generic Injectable Drugs Product
Table 99. Gland Pharma Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 100. Gland Pharma Recent Development
Table 101. Endo International PLC Company Details
Table 102. Endo International PLC Business Overview
Table 103. Endo International PLC Generic Injectable Drugs Product
Table 104. Endo International PLC Revenue in Generic Injectable Drugs Business (2020-2025) & (US$ Million)
Table 105. Endo International PLC Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Generic Injectable Drugs Picture
Figure 2. Global Generic Injectable Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Generic Injectable Drugs Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule Features
Figure 5. Large Molecule Features
Figure 6. Global Generic Injectable Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Generic Injectable Drugs Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Anesthesia Case Studies
Figure 10. Anti-Infectives Case Studies
Figure 11. Parenteral Nutrition Case Studies
Figure 12. Cardiovascular Diseases Case Studies
Figure 13. Generic Injectable Drugs Report Years Considered
Figure 14. Global Generic Injectable Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Generic Injectable Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Generic Injectable Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Generic Injectable Drugs Market Share by Players in 2024
Figure 18. Global Top Generic Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectable Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Generic Injectable Drugs Revenue in 2024
Figure 20. North America Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Generic Injectable Drugs Market Share by Country (2020-2031)
Figure 22. United States Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Generic Injectable Drugs Market Share by Country (2020-2031)
Figure 26. Germany Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Generic Injectable Drugs Market Share by Region (2020-2031)
Figure 34. China Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Generic Injectable Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Generic Injectable Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Generic Injectable Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Hospira (Pfizer Inc.) Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 50. Fresenius Kabi Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 51. Sandoz (Novartis) Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 52. Hikma Pharmaceuticals PLC Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 53. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 54. Grifols Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 55. Nichi-Iko Group (Sagent) Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 56. Teva Pharmaceutical Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 57. Auromedics Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 58. Sanofi Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 59. Gland Pharma Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 60. Endo International PLC Revenue Growth Rate in Generic Injectable Drugs Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232